Back to Search Start Over

A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer.

Authors :
Li H
Mao Y
Xiong Y
Zhao HH
Shen F
Gao X
Yang P
Liu X
Fu D
Source :
Cancer genomics & proteomics [Cancer Genomics Proteomics] 2019 Jan-Feb; Vol. 16 (1), pp. 81-89.
Publication Year :
2019

Abstract

Background/aim: Pancreatic cancer (PC) is currently the fourth leading cause of cancer-related mortality worldwide. Peripheral blood mononuclear cells (PBMCs) is a subpopulation of accessible and functional immune cells. Comparative analysis of the proteome of PBMCs can help us elucidate the mechanism of disease and find potential biomarkers for diagnosis.<br />Materials and Methods: PBMCs were collected from healthy individuals, patients with benign diseases, and pancreatic cancer. iTRAQ-2DLC-MS/MS and SWATH methodologies were applied to make a comparative proteomics analysis of PBMCs.<br />Results: A total of 3,357 proteins with a false discovery rate (FDR) <1% were identified, of which 114 proteins were found dysregulated in the PC group. An extensive SWATH library was constructed which showed a potential application for large scale clinical sample analysis.<br />Conclusion: A PBMCs proteome with extensive protein representation was achieved, which will potentially allow the identification of novel biomarkers for PC.<br /> (Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)

Details

Language :
English
ISSN :
1790-6245
Volume :
16
Issue :
1
Database :
MEDLINE
Journal :
Cancer genomics & proteomics
Publication Type :
Academic Journal
Accession number :
30587502
Full Text :
https://doi.org/10.21873/cgp.20114